Hand transplants, Penny stock scams and more

Here’s part 3 of 3 from this week’s Live Q&A Conference Call.

Last thing I will mention today. I finally talked to my friend, the guy who basically invented dual-hand transplant surgeries at Johns Hopkins. And, I asked him those detailed fundamental questions that we have been waiting to ask him about Axogen. Long story short, he still thinks the company is doing all the right things.

He is co-authorizing a research paper that has their name on it. He sees them at conferences. He sees them when he talks to surgeons. He presents with them. He thinks they continue to dominate and not just dominate, they are the only real solution in that cadaver-nerve solution world out there right now. The artificial nerve companies are not delivering. The technology is not as good. He reads Trading with Cody and he said he saw that I mentioned the potential for a conflict of interest if he were to own stock in Axogen and he says, that’s exactly right. He is doing research on how to do better body transplants. He’s trying to change the world and saves lives and make the world better and he doesn’t want a hint of influence in his research from owning stock in a company related to his research. Forgetting about perception, he doesn’t even want his own mind to think he prefers Axogen’s nerve products to any other concept out there for any reason other than that’s what his research shows him. He doesn’t own the stock and he truly still believes it is the best solution out there.

One of the things he also said was that emboldens his confidence in the company is that when they put the conduit (when they are connecting the nerves in a hand to the nerves in an arm), the FDA says you can be up to 10 millimeters in length for the conduit. He said, “You know Cody, the problem is that it looks like what we are learning over the last ten years is that 10 mm is just a dream. Nerves don’t regenerate 10 millimeters across, it’s five or six mm is the max. Axogen doesn’t sell 10 millimeters. They limit their conduits 6 or 8 mm so that nerves are able to be connected and it actually works. They don’t have to do it that way, but they do it that way.”

I like hearing that stuff. We’ve got a triple in Axogen already and I have trimmed a little but, cut maybe once or twice like most things. But longer-term, it sounds like all systems go there. Neat company.

One last thing, I will mention. He also said have you heard of this company with the stock symbol $COOL? I said “No, why?” He said that a couple of months ago a couple of his colleagues left John Hopkins, and they weren’t necessarily the most popular guys over here, and now one of them is the CEO of this company. They just did a reverse merger with a penny stock that was a video game distribution company. And now they are changing the name of that penny stock from Majesco Entertainment to Polarityte and keeping the COOL stock symbol. I start looking at their filings with them while I am on the phone with him and I was shocked to see how they still talk about the video game industry as well as their new biotech industry in their recent quarterly report. I am telling you guys, it looks like another one of those classic penny stock scams that you want to stay away from. COOL was at $3 two months ago after reverse merger, after reverse split moved it up. They’ve been issuing press release after press release about these seemingly well-respected medical field people joining the company. I would run for the hills. It is amazing this stuff goes on.

For the record, I immediately said “Dude, can you borrow $COOL?” and I immediately went over and checked on mine and no you can’t borrow shares of $COOL. It is classic microcap penny stock merger crap thing that, if you could short it, you could probably make some good money, but I would guess a year from now that stock is back below $3. Don’t buy it at least.

This transcript and these new conference calls are Trading With Cody exclusives. We put out a podcast on some of this stuff, but the transcript itself has everything that was discussed. The podcasts are going to be edited down from now on, if only to keep value for you dear Trading With Cody subscribers. I don’t want the rest of the world to get access to our full one hour call.

All right everybody. Peace. Love. Happiness. Thanks for all the well wishes for Amaris. Family first. Thanks guys.